Dian Diagnostics Group Co.,Ltd. (SHE:300244)
China · Delayed Price · Currency is CNY 16.25
-0.57 (-3.39%)
Jun 8, 2026, 3:04 PM CST
Dian Diagnostics Group Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Dian Diagnostics Group stock has a consensus rating of "Buy" and an average price target of ¥18.84. The average 1-year stock price forecast is 15.94% higher than the current stock price, while the lowest is ¥14.00 (-13.85%) and the highest is ¥24.46 (+50.52%).
Price Target: ¥18.84 (+15.94%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Dian Diagnostics Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 3 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 8 | 8 | 7 | 7 | 8 | 8 |
Financial Forecast
Revenue This Year
9.93B
from 10.10B
Decreased by -1.61%
Revenue Next Year
10.40B
from 9.93B
Increased by 4.66%
EPS This Year
0.73
from 0.02
Increased by 3,662.89%
EPS Next Year
0.66
from 0.73
Decreased by -10.27%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 10.6B | ||
| Avg | 9.9B | ||
| Low | 9.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.0% | ||
| Avg | -1.6% | ||
| Low | -6.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 0.73 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 3,662.9% | ||
| Low | - |